BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 37925866)

  • 1. Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review.
    Gunawan M; Boonkanokwong V
    Colloids Surf B Biointerfaces; 2024 Jan; 233():113608. PubMed ID: 37925866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
    Okur NÜ; Siafaka PI; Gökçe EH
    Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications.
    Nunes S; Madureira AR; Campos D; Sarmento B; Gomes AM; Pintado M; Reis F
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1863-1873. PubMed ID: 26192708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-Based Nanocarrier System for the Effective Delivery of Nutraceuticals.
    Subramanian P
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in nanocarriers for nutrient delivery.
    Gorantla S; Wadhwa G; Jain S; Sankar S; Nuwal K; Mahmood A; Dubey SK; Taliyan R; Kesharwani P; Singhvi G
    Drug Deliv Transl Res; 2022 Oct; 12(10):2359-2384. PubMed ID: 34845678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structured edible lipid-based particle systems for oral drug-delivery.
    Ashkar A; Sosnik A; Davidovich-Pinhas M
    Biotechnol Adv; 2022; 54():107789. PubMed ID: 34186162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel protein-lipid composite nanoparticles with an inner aqueous compartment as delivery systems of hydrophilic nutraceutical compounds.
    Liu G; Huang W; Babii O; Gong X; Tian Z; Yang J; Wang Y; Jacobs RL; Donna V; Lavasanifar A; Chen L
    Nanoscale; 2018 Jun; 10(22):10629-10640. PubMed ID: 29845181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.
    Neves AR; Lúcio M; Martins S; Lima JL; Reis S
    Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
    Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
    Das S; Chaudhury A
    AAPS PharmSciTech; 2011 Mar; 12(1):62-76. PubMed ID: 21174180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins.
    Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutraceuticals and Food-Grade Lipid Nanoparticles: From Natural Sources to a Circular Bioeconomy Approach.
    Blanco-Llamero C; Fonseca J; Durazzo A; Lucarini M; Santini A; Señoráns FJ; Souto EB
    Foods; 2022 Aug; 11(15):. PubMed ID: 35954085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approaches in lipid-based nanocarriers for oral drug delivery.
    Plaza-Oliver M; Santander-Ortega MJ; Lozano MV
    Drug Deliv Transl Res; 2021 Apr; 11(2):471-497. PubMed ID: 33528830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.
    Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
    Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
    Talegaonkar S; Bhattacharyya A
    AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers.
    Lin CH; Chen CH; Lin ZC; Fang JY
    J Food Drug Anal; 2017 Apr; 25(2):219-234. PubMed ID: 28911663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals.
    Neves AR; Martins S; Segundo MA; Reis S
    Nutrients; 2016 Mar; 8(3):131. PubMed ID: 26950147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured Lipid Carriers- A Versatile Carrier for Oral Delivery of Lipophilic Drugs.
    Patel P; Patel M
    Recent Pat Nanotechnol; 2021; 15(2):154-164. PubMed ID: 32912129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin.
    Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.